Literature DB >> 7934410

Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.

W A Lynn, E Clutterbuck, S Want, V Markides, S Lacey, T R Rogers, J Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7934410     DOI： 10.1016/s0140-6736(94)91687-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Authors:  H M Lamb; D P Figgitt; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

3.  Pharmacokinetics of quinupristin-dalfopristin in continuous ambulatory peritoneal dialysis patients.

Authors:  C A Johnson; C A Taylor; S W Zimmerman; W E Bridson; P Chevalier; O Pasquier; R I Baybutt
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 4.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 5.  Future prospects and therapeutic potential of streptogramins.

Authors:  E Rubinstein; N Keller
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 6.  Treatment options for vancomycin-resistant enterococcal infections.

Authors:  Peter K Linden
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient.

Authors:  In Ji Song; Ji Won Seo; Young Eun Kwon; Young Ly Kim; Tae Seop Lim; Ea Wha Kang; Tae Ik Chang
Journal:  Perit Dial Int       Date:  2014 Mar-Apr       Impact factor: 1.756

Review 8.  Quinupristin-dalfopristin.

Authors:  H M Bryson; C M Spencer
Journal:  Drugs       Date:  1996-09       Impact factor: 9.546

9.  Vancomycin-resistant peritonitis associated with peritoneal dialysis: a cause for concern.

Authors:  A O'Riordan; K A Abraham; J Kee Ho; J J Walshe
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

10.  Life-threatening infection with multiresistant Staphylococcus epidermidis in a patient with end-stage renal disease: cure with chloramphenicol and quinupristin/dalfopristin (RP 59500).

Authors:  E Mündlein; H von Baum; H K Geiss; M Springsklee; M Zeier; K Andrassy
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.